“I am pleased to welcome Susan to the PharmaLink family,” said Thierry Beckers, President & CEO at PharmaLink. “Her exceptional talents and diverse leadership experience will position her as an asset to our growing organization.”
PharmaLink’s series of expansion initiatives have continued to progress since the launch in March 2020. Phase I was comprised of moving the designated operations and administrative functions to a new area. Once that move was completed, space became available to begin planning and implementing Phase II.
As we continue to navigate through the COVID-19 pandemic, we have experienced some of the most challenging and uncertain times in recent history. This crisis has required us to take bold actions to preserve the safety and welfare of our employees and customers.